{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:22:17Z","timestamp":1775370137171,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1016\/0014-2999(92)90634-g","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T05:20:38Z","timestamp":1039843238000},"page":"439-443","source":"Crossref","is-referenced-by-count":77,"title":["The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way"],"prefix":"10.1016","volume":"213","author":[{"given":"Johannes C.","family":"Stoof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Drukarch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Ch.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0014-2999(92)90634-G_BIB1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science"},{"key":"10.1016\/0014-2999(92)90634-G_BIB2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1471-4159.1989.tb07244.x","article-title":"Stimulation of D2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+","volume":"52","author":"Drukarch","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/0014-2999(92)90634-G_BIB3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","article-title":"NMDA-antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats","volume":"28","author":"Klockgether","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/0014-2999(92)90634-G_BIB4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","article-title":"Effects of the 1-amino-adamantanes at the MK-801 binding site of the NMDA-receptor-gated ion channel: a human post-mortem brain study","volume":"206","author":"Kornhuber","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0014-2999(92)90634-G_BIB5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2125.1976.tb00642.x","article-title":"Effect of amantadine on drug-induced parkinsonism: relationship between plasma levels and effect","volume":"3","author":"Pacifici","year":"1976","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/0014-2999(92)90634-G_BIB6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/297422a0","article-title":"N-Methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids","volume":"297","author":"Scatton","year":"1982","journal-title":"Nature"},{"key":"10.1016\/0014-2999(92)90634-G_BIB7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.208.7.1168","article-title":"Amantadine in the treatment of Parkinson's disease","volume":"208","author":"Schwab","year":"1969","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/0014-2999(92)90634-G_BIB8","doi-asserted-by":"crossref","unstructured":"Stoof, J.C., B. Drukarch, P. De Boer, B.H.C. Westerink and H.J. Groenewegen, Regulation of the activity of striatal cholinergic neurons by dopamine, Neuroscience (in press).","DOI":"10.1016\/0306-4522(92)90027-Y"},{"key":"10.1016\/0014-2999(92)90634-G_BIB9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.174.4007.408","article-title":"Dopamine: release from the brain in vivo by amantadine","volume":"174","author":"Von Voigtlander","year":"1971","journal-title":"Science"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001429999290634G?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001429999290634G?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T08:28:42Z","timestamp":1554193722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/001429999290634G"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["001429999290634G"],"URL":"https:\/\/doi.org\/10.1016\/0014-2999(92)90634-g","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}